Denervation of the renal arteries in metabolic syndrome: The DREAMS-study

Hypertension

Volumn 65, Issue 4, 2015, Pages 751-757

  Verloop, Willemien L ^a   Spiering, Wilko ^a   Vink, Eva E ^a   Beeftink, Martine M A ^a   Blankestijn, Peter J ^a   Doevendans, Pieter A ^a   Voskuil, Michiel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

blood pressure; insulin resistance; metabolic syndrome X; renal denervation; sympathetic nerve activity

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION THERAPY; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HEART RATE VARIABILITY; HUMAN; INSULIN SENSITIVITY; KIDNEY ARTERY; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; MALE; METABOLIC SYNDROME X; MUSCLE SYMPATHETIC NERVE ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF MONITORING; SYMPATHETIC TONE; TRANSIENT ISCHEMIC ATTACK; ADRENERGIC SYSTEM; BLOOD; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INNERVATION; INSULIN RESISTANCE; KIDNEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SYMPATHECTOMY; TREATMENT OUTCOME;

GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; KIDNEY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84929133637     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04798     Document Type: Article

References (37)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640-1645. doi: 10.1161/CIRCULATIONAHA.109.192644
2. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013; 62: 697-703. doi: 10.1016/j.jacc.2013.05.064
3. Goldberg RB, Mather K. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program. Arterioscler Thromb Vasc Biol. 2012; 32: 2077-2090. doi: 10.1161/ATVBAHA.111.241893
4. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004; 44: 847-852. doi: 10.1161/01. HYP.0000147893.08533.d8
5. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev. 2010; 6: 58-67
6. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension. 2003; 41(3 Pt 2): 621-624. doi: 10.1161/01. HYP.0000047205.52509.8A
7. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension. 2009; 54: 1195-1201. doi: 10.1161/HYPERTENSIONAHA.109.138610
8. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009; 373: 1275-1281. doi: 10.1016/S0140-6736(09)60566-3
9. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet. 2010; 376: 1903-1909
10. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014; 370: 1393-1401. doi: 10.1056/NEJMoa1402670
11. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011; 123: 1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869
12. Verloop WL, Vink EE, Voskuil M, Vonken EJ, Rookmaaker MB, Bots ML, Doevendans PA, Blankestijn PJ, Spiering W. Eligibility for percutaneous renal denervation: the importance of a systematic screening. J Hypertens. 2013; 31: 1662-1668. doi: 10.1097/HJH.0b013e328362152e
13. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22: 1462-1470
14. Bastard JP, Vandernotte JM, Faraj M, Karelis AD, Messier L, Malita FM, Garrel D, Prud'homme D, Rabasa-Lhoret R. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab. 2007; 33: 261-268. doi: 10.1016/j.diabet.2007.02.004
15. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet. 1995; 346: 120-121
16. Parati G, Stergiou GS, Asmar R, et al; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010; 24: 779-785. doi: 10.1038/jhh.2010.54
17. Vink EE, Verloop WL, Siddiqi L, van Schelven LJ, Liam Oey P, Blankestijn PJ. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients. Int J Cardiol. 2014; 176: 8-12. doi: 10.1016/j.ijcard.2014.06.021
18. Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev. 1979; 59: 919-957
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612
20. Voskuil M, Verloop W. Renal denervation therapy. In: Dieter R, Dieter RJ, Dieter RI, eds. Endovascular Interventions. A Case Based Approach. 1st ed. New York: Springer; 2014: 419-427
21. Plum L, Ahmed L, Febres G, Bessler M, Inabnet W, Kunreuther E, McMahon DJ, Korner J. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring). 2011; 19: 2149-2157. doi: 10.1038/oby.2011.134
22. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB Jr, Wagenknecht LE, Stern MP, Haffner SM; San Antonio Heart Study; Mexico City Diabetes Study; Insulin Resistance Atherosclerosis Study. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes. 2003; 52: 463-469
23. Lorenzo C, Haffner SM, Stancáková A, Laakso M. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals. J Clin Endocrinol Metab. 2010; 95: 5082-5090. doi: 10.1210/jc.2010-1144
24. Pigeon E, Riou ME, St-Onge J, Couillard E, Tremblay A, Marette A, Weisnagel SJ, Joanisse DR. Validation of a simple index (SIisOGTT) of insulin sensitivity in a population of sedentary men. Diabetes Metab. 2009; 35: 398-403. doi: 10.1016/j.diabet.2009.04.007
25. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficultto-control hypertensive patients: prospective case series. Hypertension. 2012; 60: 1485-1490. doi: 10.1161/HYPERTENSIONAHA.112.201186
26. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013; 61: 457-464. doi: 10.1161/HYPERTENSIONAHA.111.00194
27. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014; 383: 622-629. doi: 10.1016/S0140-6736(13)62192-3
28. Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013; 128: 132-140. doi: 10.1161/CIRCULATIONAHA.112.000949
29. Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, Boutouyrie P, Laurent S. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens. 2010; 28: 2336-2341. doi: 10.1097/HJH.0b013e32833da2b2
30. Kjeldsen SE, Narkiewicz K, Oparil S, Hedner T. Renal denervation in treatment-resistant hypertension -Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials. Blood Press. 2014; 23: 135-137. doi: 10.3109/08037051.2014.916896
31. Asmar R, Safar M, Queneau P. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens. 2001; 14(6 Pt 1): 546-552
32. Parati G, Stergiou G, O'Brien E, et al.; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014; 32: 1359-1366. doi: 10.1097/HJH.0000000000000221
33. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999; 340: 1321-1328. doi: 10.1056/NEJM199904293401704
34. Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension. 2007; 49: 506-510. doi: 10.1161/01.HYP.0000256530.39695.a3
35. Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens. 2007; 25: 1285-1289. doi: 10.1097/HJH.0b013e3280f9df85
36. Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE. Catheterbased radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. Am J Hypertens. 2014; 27: 1285-1292. doi: 10.1093/ajh/hpu048
37. Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, Furuta Y, Aizawa Y, Iwafuchi M. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013; 61: 450-456. doi: 10.1161/HYPERTENSIONAHA.111.00095